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Abstract
Background: In mouse embryos, homozygous or heterozygous deletions of the gene encoding the Notch ligand Dll4 result
in early embryonic death due to major defects in endothelial remodeling in the yolk sac and embryo. Considering the close
developmental relationship between endothelial and hematopoietic cell lineages, which share a common mesoderm-
derived precursor, the hemangioblast, and many key regulatory molecules, we investigated whether Dll4 is also involved in
the regulation of early embryonic hematopoiesis.
Methodology/Principal Findings: Using Embryoid Bodies (EBs) derived from embryonic stem cells harboring hetero- or
homozygous Dll4 deletions, we observed that EBs from both genotypes exhibit an abnormal endothelial remodeling in the
vascular sprouts that arise late during EB differentiation, indicating that this in vitro system recapitulates the angiogenic
phenotype of Dll4 mutant embryos. However, analysis of EB development at early time points revealed that the absence of
Dll4 delays the emergence of mesoderm and severely reduces the number of blast-colony forming cells (BL-CFCs), the in
vitro counterpart of the hemangioblast, and of endothelial cells. Analysis of colony forming units (CFU) in EBs and yolk sacs
from Dll4
+/2 and Dll4
2/2 embryos, showed that primitive erythropoiesis is specifically affected by Dll4 insufficiency. In Dll4
mutant EBs, smooth muscle cells (SMCs) were seemingly unaffected and cardiomyocyte differentiation was increased,
indicating that SMC specification is Dll4-independent while a normal dose of this Notch ligand is essential for the
quantitative regulation of cardiomyogenesis.
Conclusions/Significance: This study highlights a previously unnoticed role for Dll4 in the quantitative regulation of early
hemato-vascular precursors, further indicating that it is also involved on the timely emergence of mesoderm in early
embryogenesis.
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Introduction
The first hematopoietic cells in the mouse embryo appear
shortly after gastrulation, around embryonic day (E) 7.5, in the
blood islands of the yolk sac (YS), in close association with
endothelial cells, corresponding to a transient population of
nucleated primitive erythrocytes. Primitive erythropoiesis is
followed, between E8.25 and E10.5, by a second YS hematopoi-
etic wave in which definitive erythro-myeloid progenitors are
generated [1]. In vitro and in vivo studies strongly suggest that all YS
hematopoietic cells derive from the hemangioblast, a common
precursor of hematopoietic and endothelial cell lineages [2–4].
Subsequently, the fetal liver, first colonized by YS-derived
hematopoietic progenitors and then by hematopoietic stem cells
(HSCs) arising in the intraembryonic aorta-gonad-mesonephros
(AGM) region, becomes the primary hematopoietic organ during
fetal development. Toward the end of gestation, HSCs migrate to
the bone marrow, where hematopoiesis is maintained throughout
post-natal life [1,5].
One of the major signaling pathways known to regulate several
hematopoietic developmental stages and microenvironments is the
Notch pathway [6]. In mammals, five Notch ligands, of the Delta-
like (Dll1, Dll3 and Dll4) and Jagged (Jag1 and Jag2) families can
interact with four Notch receptors (Notch1-4) leading to sequential
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34553proteolytic cleavages of the receptor that release the Notch
intracellular domain (NICD) from the plasma membrane. The
NICD migrates to the nucleus where it binds to the transcription
factor RBP-Jk, inducing the expression of several target genes by
the recruitment of co-activators [6].
The role of Notch signaling in post-natal hematopoiesis has
been extensively studied [7] but its function in embryonic
hematopoiesis, especially in the YS stage, is much less understood.
Notch1 is required for the generation of long-term HSCs at the
AGM, yet it appears to be dispensable for YS hematopoiesis [8,9].
However, several reports show that Notch signaling plays a role in
mesodermal differentiation and specification into the respective
cell lineages, which include cardiac muscle, mural, endothelial and
hematopoietic cells [9–13]. In fact, Notch1 signaling is active
during mouse gastrulation in nascent mesoderm and YS blood
islands [14], suggesting that it might have a physiological role in
early stages of mesoderm commitment and, particularly, in the
generation of early hematopoietic precursors. However, which
specific Notch ligands are involved in Notch activation during YS
hematopoiesis is completely unknown. The Notch ligand Dll4 is,
in this respect, of particular interest. Mouse embryos carrying
homozygous or heterozygous deletions of the Dll4 gene are grossly
similar to their normal counterparts until E8.75–9.0 when a
developmental delay becomes apparent. This is followed by death
of all Dll4
2/2 and (the majority) of Dll4
+/2 embryos at E9.5 and
E10.5, respectively, due to severe angiogenic defects in the YS and
embryo [15–17]. The close developmental relationship between
endothelial and hematopoietic cell lineages together with the fact
that endothelium itself is an essential microenvironment for the
generation of hematopoietic precursors [18–20], makes it plausible
that Dll4 might also be involved in the regulation of YS
hematopoiesis.
To address this issue we have made use of mouse embryonic
stem (ES) cell-derived EBs, an in vitro model that faithfully
recapitulates the in vivo dynamics of YS hematopoiesis [21,22].
Analysis of EBs generated from Dll4
+/2 and Dll4
2/2 ES cells
show that Dll4 regulates the timely emergence of mesoderm
during EB differentiation and its potential to form BL-CFCs, the
precursors of endothelial and hematopoietic cells in this experi-
mental system [3]. We also observed that a normal dose of Dll4 is
required for the emergence of primitive erythropoiesis (both in vitro
and in vivo), for the correct remodeling of endothelial cells and for
the generation of normal numbers of cardiomyocytes and
endothelial cells, while the specification of SMCs is Dll4-
independent.
Results
Expression of Dll4 during EB differentiation
Analysis of Dll4 expression in EBs differentiated from the
parental R1 (WT) ES cell line by semi-quantitative RT-PCR
showed that Dll4 is already expressed in undifferentiated ES cells,
becomes transiently up-regulated at day 1, down-regulated from
days 2 to 3, and then strongly expressed from day 4 until day 8
(Figure 1A). This expression dynamics is compatible with a role for
Dll4 in the EB pre-hemangioblast stage [23] and, subsequently, at
the time window at which primitive and definitive hematopoietic
progenitors are generated [21].
Effects of Dll4 in ES cell maintenance and EB generation
To address the role for Dll4 in embryonic hematopoiesis we
used a genetically modified R1 ES cell line in which one Dll4 allele
has been disrupted by insertion of a lacZ-neo cassette (Dll4
+/2 ES
cells) [15]. Dll4
2/2 clones were obtained from these cells by G418
selection. PCR genotyping of G418 resistant colonies revealed that
the WT Dll4 allele had been lost in three ES cell clones (#7, #9i
and #10i; Figure 1B) where the absence of Dll4 mRNA was
confirmed by RT-PCR (Figure 1C).
Dll4
+/2 and Dll4
2/2 ES cell colonies exhibited normal
undifferentiated morphology (not shown) and similar expansion
rate when compared to WT ES cells (Figure S1A). When allowed
to form EBs in liquid culture, no significant differences were
observed among WT and Dll4 mutant ES cell lines as to number
of generated EBs or EB-cellularity, cell-proliferation or apoptosis
(Figure S1 B–E). However, when the expression of a pluripoten-
tiality marker, stage-specific embryonic antigen-1 (SSEA-1) [24],
was analysed throughout EB development (percentage and
absolute numbers are in Figure S1F and Figure S2A, respectively),
a more sustained SSEA-1 expression was observed in Dll4
2/2 EBs
from day 3 until day 6, when compared to WT and Dll4
+/2 EBs.
This finding suggests that Dll4 influences ES cell differentiation.
Co-expression of SSEA-1 and Flk1, which is representative of
early mesodermal progenitors [25], is in fact patent in day 3 WT
and Dll4
+/2 EBs but only becomes evident at day 4 in Dll4
2/2
EBs (Figure 1D; absolute numbers in Figure S2B). This
observation suggests a delay in the differentiation pathway towards
mesoderm lineages in Dll4 null EBs. Also, the immuno-detection
of E-cadherin in 3D preserved EBs showed that Dll4
2/2 EBs
maintain an epiblast-like morphology at day 3, whereas in both
WT and Dll4
+/2 EBs a mesoderm-like cell population (loosely
connected E-cadherin
2 cells) is clearly visible surrounding a
compartment of E-cadherin
+ cells at the same time point
(Figure 1E).
Dll4 regulates the emergence of germ layers during EB
development
The above results assign a regulatory action of Dll4 in the timely
emergence of mesodermal cells. To further clarify this issue, we
analysed the expression pattern of several genes known to mark
the formation of mesoderm, and the other germ layers, during EB
differentiation. As shown in Figure 1F, the down-regulation of the
pluripotentiality marker Rex1 [26] and the emergence of the
primitive ectoderm marker FGF5 [27] was not apparently affected
in Dll4 mutant EBs. However, in Dll4
2/2 EBs, FGF5 expression
was maintained until day 5, while in WT and Dll4
+/2 EBs it was
only present until day 3 of differentiation, suggesting a delay in the
differentiation of ES cells when Dll4 is absent. Consistent with this
notion, the appearance of the mesodermal marker Brachyury [28]
was 24 hours delayed (and its levels reduced) in Dll4
2/2 EBs
(Figure 1F and Figure S1G). The emergence of primitive
endoderm, as assessed by Gata6 expression [29], was also delayed
in Dll4
2/2 EBs. In contrast, increased expression of the
neuroectodermal gene Pax6 [30] was observed in Dll4
+/2 and in
Dll4
2/2 EBs (more pronounced in the latter; Figure 1F).
These results show that Dll4 is not essential for ES cell
maintenance while strongly suggesting that it regulates the timing
of germ layer emergence during EB development, promoting
mesoderm formation while inhibiting that of neuroectoderm.
Dll4 regulates the generation of Flk1
+ mesodermal cells
and hemangioblasts
The earliest marker of mesodermal differentiation towards
hemato-vascular development is Flk1, the receptor-2 of vascular
endothelial growth factor (VEGF) [31,32]. As shown in Figure 2A,
WT and Dll4
+/2 EB cells exhibited similar dynamics of Flk1
expression, with the first Flk1
+ cells appearing at day 2, followed
by a peak 24 hours later when near 50% of EB cells become Flk1
+.
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2/2 EBs showed a 24 hour delay in the
emergence of this cell population, being almost devoid of Flk1
+
cells until day 3 of differentiation. Thereafter, Flk1
+ cells increased,
reaching its peak (not exceeding 30%) at day 4 (Figure 2A;
absolute cell numbers in Figure S2C). Flk1 expression dynamics is
in fact similar to that of cells co-expressing SSEA-1 and Flk1 (see
above; Figure S2B), which represent early mesodermal progenitors
[25]. Thus, the absence of Dll4 delays the emergence of Flk1
+ cells
and severely reduces their number in differentiating EBs.
Figure 1. Generation and characterization of Dll4 mutant EBs. (A) Semi-quantitative RT-PCR analysis of Dll4 expression in EBs generated from
WT-R1 ES cells, from day 0 to day 8. Data representative of three independent experiments. (B) PCR genotyping of WT and mutant Dll4 alleles of WT,
Dll4
+/2 and three Dll4
2/2 (#7, #9i and #10i) ES cell lines. (C) Semi-quantitative RT-PCR analysis of Dll4 expression in WT, Dll4
+/2 and Dll4
2/2 EBs with
3 days of differentiation. (D) Representative flow cytometry dot-plot of SSEA-1/Flk1 expression in WT, Dll4
+/2 and Dll4
2/2 EBs from day 3 to day 4.5.
(E) Immunofluorescence detection of E-cadherin (membrane bright staining), counterstained with DAPI (nuclear gray staining), of WT, Dll4
+/2 and
Dll4
2/2 (#7) EBs with 3 days of differentiation. (F) Semi-quantitative RT-PCR analysis of Rex1, and genes involved in the formation of germ layers in
WT, Dll4
+/2 and Dll4
2/2 EBs from day 0 to day 8 of differentiation. Data representative of three independent experiments. Scale bar represents
10 mm.
doi:10.1371/journal.pone.0034553.g001
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PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e34553Figure 2. Analysis of Flk1 expression and BL-CFC potential of WT and Dll4 mutant EBs. (A) Flow cytometry analysis of Flk1 expression in
WT, Dll4
+/2 and Dll4
2/2 EBs from day 2 to day 6 of differentiation. (B) Number of blast colonies generated by WT, Dll4
+/2 and Dll4
2/2 EB cells from
day 2 to day 5 of differentiation. (C) Number of blast colonies generated by sorted Flk1 cells derived from day 2.5 WT and Dll4
+/2 EBs and from day
3.5 Dll4
2/2 EBs. (D) Number of blast colonies generated by day 3 EBs (upper) or sorted Flk1 cells (bottom) differentiated from WT and Dll4
2/2 ES cells
transduced with empty (pMigR1) or recombinant virus (pMigR1-Dll4). (E) Representative flow cytometry dot-plot of Flk1/PdgfR-a expression from day
3 to day 4 of WT, Dll4
+/2 and Dll4
2/2 EBs (Flk1
+/PdgfR-a
+: day 3 - WT and Dll4
+/2 versus #7, 0.00060,P,0.0406; Flk1
+/PdgfR-a
2: day 3 to day 4 - WT
and Dll4
+/2 versus #7, 0.0002,P, 0.0094; day 4 - WT versus Dll4
+/2, P=0.0457). ND not determined. *P,.05, **P,.01, ***P,.001.
doi:10.1371/journal.pone.0034553.g002
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+ subpopu-
lation [23], we proceeded to analyze the potential of WT, Dll4
+/2
and Dll4
2/2 EBs to generate BL-CFCs, from day 2 to day 5. As
shown in Figure 2B, WT EBs exhibited the characteristic transient
wave of BL-CFC potential [2], with cells from day 2.5 and day 3
EBs generating the highest number of blast colonies. Similar
kinetics was observed in Dll4
+/2 EBs, which produced a reduced
(but statistically non-significant) number of blast colonies, at days
2.5 and 3, when compared to those of control EBs. A striking
reduction in the number of blast colonies was, however, observed
in Dll4
2/2 EBs at these time-points. Similar results were obtained
in EBs derived from the other Dll4 null clones (analysed at day 3;
Figure S3A). The capacity to generate BL-CFC was further
assessed in sorted Flk1
+ versus the Flk1
2 EB cell population. The
analysis was performed at day 2.5 for WT and Dll4
+/2 EBs, and at
day 3.5 for Dll4
2/2 EBs, because the emergence of Flk1
+
mesoderm was found to be delayed 24 hours in the absence of
Dll4 (see above). In all cases, the BL-CFC potential was virtually
absent from Flk1
2 EB cells, and a significantly decreased capacity
to generate BL-CFC was observed in Flk1
+ cells sorted from
Dll4
2/2 EBs when compared to those isolated from WT and
Dll4
+/2 EBs (Figure 2C). A close inspection throughout the
sequential stages of blast colony development [33] revealed that
Dll4 null (and Dll4
+/2) blast colonies were always morphologically
undistinguishable from those generated by WT cells (not shown).
These results strongly suggest that the absence of Dll4 severely
decreases the emergence of Flk1
+ cells in the EB and the ability of
these cells to differentiate into BL-CFC.
To further confirm that the BL-CFC phenotype of Dll4
2/2 EBs
was due to loss of Dll4, Dll4
2/2 ES cells (#7) were transduced
with a retrovirus containing the full-length Dll4 cDNA and blast
colony assays performed at day 3 of EB differentiation from total
and Flk1
+ sorted cells. At this time point, only 30–50% of EB cells
expressed GFP, an indication that retroviral silencing has occurred
in the remaining cells [34]. Despite this fact, Dll4-transduced EBs
still generated significantly higher numbers of blast colonies when
compared to those transduced with the empty virus (control;
Figure 2D). The percentage of Flk1
+ EB cells, which was found to
be reduced in Dll4
2/2 EBs (see above), also significantly increased
in Dll4-transduced day 3 EBs when compared to the control
(Figure S3B).
The hematopoietic subpopulation of Flk1
+ cells can be
distinguished from Flk1
+ cells exhibiting cardiac potential by the
co-expression of PdgfR-a in the latter [35]. As shown in Figure 2E
the vast majority of Flk1
+ cells from Dll4
2/2 EBs co-expressed
PdgfR-a, indicative of its enhanced cardiac differentiation and
reduced hemangiogenic potential when compared with WT and
Dll4
+/2 Flk1
+ cells (see below).
Together, these results show that the absence of Dll4 delays the
emergence of Flk1
+ mesodermal cells in the EB and, within this
population, reduces the generation of cells with hemangioblast
potential.
Dll4 heterozygosity specifically affects primitive
erythropoiesis both in vitro and in vivo
We then investigated the effects of mono- and bi-allelic deletion
of Dll4 on the generation of hematopoietic cells. The expression of
CD41, the earliest marker of embryonic hematopoietic progeni-
tors [36] was analysed during EB differentiation. When compared
to WT EBs, a clear reduction in CD41
+ cells was observed in Dll4
mutant EBs, more pronounced in Dll4
2/2 EBs (Figure 3A;
absolute numbers in Figure S2D). Consistent with these observa-
tions, decreased expression of Scl, Gata1, and Runx1, transcription
factors known to be essential for hemangioblast/hematopoietic
development [22], was observed in Dll4
2/2 EBs (Figure S4A).
While these results indicate that Dll4 mutant EBs have reduced
hematopoietic potential, they do not discriminate between a
generalized hematopoietic problem and a restricted cell-lineage
defect. The capacity of EB cells to generate specific colony forming
units (CFUs) was thus investigated, from day 4 to day 8 of EB
differentiation. Dll4
+/2 EBs showed a dramatic reduction in the
number of primitive erythroid (EryP) progenitors relative to
control EBs (Figure 3B). However, definitive hematopoietic
progenitors were not significantly reduced in Dll4
+/2 EBs,
indicating that definitive erythro-myeloid progenitors remain
almost unaffected by Dll4 heterozygosity (Figure 3C–D). In
contrast, Dll4
2/2 EBs exhibited a strong reduction in all
hematopoietic progenitors (Figure 3B–D), consistent with their
diminished hemangioblast potential. Once again, no morpholog-
ical differences were observed in Dll4 mutant colonies when
compared with the control (not shown).
To determine if YSs derived from Dll4 mutant embryos have a
similar hematopoietic phenotype to that observed in vitro, CFU
analysis was also performed in YSs derived from WT, Dll4
+/2 and
Dll4
2/2 mouse embryos. As shown in Figure 3E, a severe
reduction in the number of EryP progenitors was observed in both
Dll4
+/2 and Dll4
2/2 YSs at E8.0, E8.5 and E9.0 (Dll4
2/2 YSs
not analyzed at E9.0) when compared to the control. However,
definitive erythro-myeloid progenitors were not reduced in Dll4
mutant YSs, indicating that Dll4 is not essential for the generation
of definitive YS hematopoietic progenitors in vivo (Figure 3F).
To better define the role of Dll4 in primitive erythropoiesis,
namely to probe for a Dll4-specific positive influence, WT and
Dll4
+/2 ES cells were differentiated on parental OP9 cells (OP9-
WT) or OP9 cells transduced either with retroviral vectors
containing Dll4 (OP9-Dll4), Dll1 (OP9-Dll1) or only IRES-eGFP
sequences (OP9-Empty) [37], and then further plated for primitive
erythroid colony assays. As shown in Figure 3G, WT and Dll4
+/2
cells differentiated on OP9-Dll4 generated a higher number of
primitive erythroid colonies when compared to the ones from
control feeder layers (OP9-WT and OP9-Empty), or to those co-
cultured onOP9-Dll1 cells.Thelower EryP potentialof the Dll4
+/2
cells found in the EB differentiation system (see above) did not occur
in OP9 co-cultures. While no further experiments were performed
to specifically address this issue, it is plausible that such different
behaviour may be related to the fact that, in Dll4
+/2 EBs, all
potentially signalling-cells exhibit Dll4 heterozygosity, while in OP9
co-cultures Dll4
+/2 ES cells were differentiated on feeder layers
expressing normal (e.g. OP9-WT) or higher Dll4 levels (OP9-Dll4).
Our data shows that the notch-ligand Dll4 differentially
influences the generation and development of specific hematopoi-
etic cell lineages. Importantly, the lack of one Dll4 allele was
sufficient to induce a marked reduction of primitive erythropoiesis,
both in vitro and in vivo. Additionally, our results from OP9 co-
cultures showed that exposure to higher levels of Dll4, but not of
Dll1, results in increased primitive erythropoiesis, stressing the
hypothesis of a ligand-specific effect.
Dll4 mutant EBs display endothelial remodelling defects
The endothelium is another cell lineage derived from the
hemangioblast and, as well, from a subpopulation of Flk1
+ cells
known to appear at day 4.25 of EB development [38]. Therefore,
endothelial differentiation was investigated throughout EB devel-
opment. The percentage and number (Figure 4A, and Figure S2E,
respectively) of endothelial cells (Tie2
+/Flk1
+/CD41
2 cells) in
Dll4
+/2 EBs was found to be similar to those of control EBs, with
the exception of day 5 where a significant reduction in the
DLL4 and Hemangioblast Development
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34553Figure 3. Effects of Dll4 in hematopoiesis. (A) Flow cytometry analysis of CD41 expression in WT, Dll4
+/2 and Dll4
2/2 EBs from day 3.5 to day 6
of differentiation. (B) Number of CFU-EryP; (C) CFU-definitive erythroid (EryD) and (D) total definitive CFUs (include CFU-EryD, -macrophage, -
granulocyte, -granulocyte//macrophage and -erythroid/granulocyte/macrophage) generated by WT, Dll4
+/2 and Dll4
2/2 EB cells at days 4, 5, 6 and 8
of differentiation. (E–F) Number of CFU-EryP (E) and total definitive CFUs (F) generated by YS cells from WT, Dll4
+/2 and Dll4
2/2 mouse embryos at
E8.0, E8.5 and E9.0. Each symbol represents individual YS and horizontal lines indicate the mean value. (G) Number of CFU-EryP generated by WT and
Dll4
+/2 cells at day 5 of differentiation on parental OP9 cells (OP9-WT) or OP9 cells transduced either with retroviral vectors containing Dll4 (OP9-Dll4),
Dll1 (OP9-Dll1) or only IRES-eGFP sequences (OP9-Empty). ND not determined. *P,.05, **P,.01, ***P,.001.
doi:10.1371/journal.pone.0034553.g003
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endothelial cells was consistently present in Dll4
2/2 EBs, once
again in agreement with the reduction of their hemangioblast
potential and Flk1 expression.
At later stages of differentiation (beyond day 10), EBs cultured
in methylcellulose medium developed sprouts (Figure 4B–G)
which were positive for the endothelial cell marker CD31
(PECAM-1) (Figure 4D). Striking morphological differences were
found between WT and Dll4 mutant EBs. As shown in Figure 4B–
D, in the former, sprouts were well defined, frequently branched
and made of two parallel cell monolayers separated by a lumen. In
contrast, Dll4
+/2 EB sprouts were generally formed by one single
monolayer of cells without a visible lumen and with less frequent
branching. Moreover, two classes of Dll4
+/2 EBs were found, both
maintaining the described endothelial sprout morphology but
differing in sprout quantity: with very few sprouts (class I) or with
abundant sprouts (class II) (Figure 4E and F). Dll4
2/2 EBs with
endothelial sprouts exhibited a phenotype very similar to class II
Dll4
+/2 EBs (Figure 4G).
Together, our data show that Dll4 mutant EBs are capable of
generating endothelial cells (albeit at reduced levels in Dll4
2/2
EBs) but the remodelling of these cells into normal vascular
structures is severely affected, akin to what happens in Dll4 mutant
embryos.
Dll4 is not essential for smooth muscle cell differentiation
but inhibits cardiomyogenesis
As SMCs are important for vascular maturation and remodel-
ling, they might play a role in the angiogenic defects observed in
Dll4 mutant EBs. To investigate the effects of Dll4 on smooth
muscle differentiation, cells isolated from day 3 EBs were cultured
in matrigel-coated wells for 5 days in the presence of VEGF and
basic fibroblast growth factor (bFGF), conditions known to
promote the proliferation and differentiation of SMCs and
endothelial cells [39]. The presence of SMCs was then assessed
by immuno-detection of a-smooth muscle actin (aSMA)
(Figure 5A–C). Similar proportions of SMCs were observed in
WT, Dll4
+/2 and Dll4
2/2 cultures (Figure 5D). In contrast,
endothelial cells (as determined by flow cytometry analysis of
Tie2
+/Flk1
+/VE-cadherin
+ cells; not shown) were markedly
reduced in Dll4
2/2 cultures when compared to their WT and
Dll4
+/2 counterparts (0.4%60.2 versus 20.74%69.7 in WT and,
13.6%63.8 in Dll4
+/2 conditions; P,0.05), confirming that the
absence of Dll4 specifically hampers the emergence of this cell
lineage (see data from EB cultures in Figure 4A).
As BL-CFCs also have the potential to generate vascular SMCs
[40], blast colonies with 4 days of development were also cultured
as described above [39]. After 4 days, SMCs were present at
similar levels in cultures of WT, Dll4
+/2 and Dll4
2/2 blast colony-
derived cells (not shown). These results indicate that differentiation
of SMCs either from the hemangioblast or from other EB cells
with SMC potential [38] is not affected by diminished Dll4
signalling.
The generation of cardiomyocytes, another mesoderm-derived
cell lineage generated in developing EBs [35,38,41] was analyzed
by the direct visualization of rhythmic contractile regions that
spontaneously appear during EB differentiation and, by expression
of the Nkx2-5 gene, one of the earliest cardiac marker genes [42].
As shown in Figure 5E, the proportion of EBs with contractile
regions (beating EBs) was significantly higher in Dll4
+/2 and
Dll4
2/2 EBs than in WT EBs, with most of the latter EBs
exhibiting contractile regions beyond day 7 of differentiation. This
observation is supported by our finding that the vast majority of
Flk1
+ cells from Dll4 null EBs co-express PdgfR-a, indicative of
enhanced cardiac differentiation [35], when compared with the
WT and Dll4
+/2 Flk1
+ cell population (see above; Figure 2E).
Accordingly, an increase in Nkx2-5 expression was observed in
Dll4
+/2 and Dll4
2/2 EBs, when compared with WT EBs
(Figure 5F).
Together, our results indicate that Dll4 affects the differentia-
tion of distinct mesoderm-derived cell lineages in different ways,
promoting hemato-vascular potential while inhibiting cardiomyo-
genesis.
Discussion
We showed that Dll4 is involved in the timely emergence of
mesoderm in differentiating EBs, subsequently favoring the
generation of hemangioblasts and primitive erythroid cells. We
also observed that Dll4 has differential effects in other mesoderm-
derived cell lineages, promoting endothelial differentiation,
inhibiting cardiomyogenesis while not affecting the specification
of SMCs (Figure 6).
Figure 4. Endothelial differentiation and remodelling defects
in Dll4 mutant EBs. (A) Flow cytometry analysis of Tie2
+Flk1
+CD41
2
cells in WT, Dll4
+/2 and Dll4
2/2 EBs from day 3 to day 6 of
differentiation. (B) Bright field image of a WT EB, at day 25 of
differentiation, showing sprouts in methylcellulose medium. (C–D) Inset
shows the correspondent confocal images for DAPI (C) and PECAM-1
(D) staining of EB sprouts. (E–G) Representative bright field images of
Dll4
+/2 (class I and II sprouts; E–F) and Dll4
2/2 (clone #9i; G) EBs with
endothelial sprouts, cultured for 25 days in methylcellulose medium.
Scale bar represents 100 mm. ND not determined. *P,.05, **P,.01,
***P,.001.
doi:10.1371/journal.pone.0034553.g004
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morphology and growth of undifferentiated ES cells. Several
observations, however, indicated that the absence of Dll4 was
temporally affecting the emergence of mesodermal cells, an event
known to occur at days 2–2.5 of EB differentiation [23]. First,
Dll4
2/2 EBs derived from independent Dll4 null ES clones
persisted in an immature state for a longer period than their
heterozygous and normal counterparts, as assessed by mainte-
nance of an epiblast-like morphology at day 3, sustained
expression of SSEA-1 until day 6, persistence of the primitive
ectoderm marker FGF5 until day 5, together with a delayed
expression of Gata6, a primitive endoderm marker. Second, the
Figure 5. Differential effects of Dll4 on the emergence of SMCs and cardiomyocytes. (A–C) Representative immunofluorescence images
for aSMA (cytoplasmic positive fibers), counterstained with DAPI (nuclear staining), of day 3 EB-derived cells cultured for 5 days in monolayer culture.
(D) Percentage of aSMA
+ cells obtained from day 3 EB-derived cells of WT, Dll4
+/2 and Dll4
2/2 cell lines. (E) Percentage of beating EBs in suspension
culture from day 5 to day 9 of differentiation. (F) Semi-quantitative RT-PCR analysis of Nkx2-5 in WT, Dll4
+/2 and Dll4
2/2 EBs from day 3 to day 8 of
differentiation. Scale bar represents 10 mm. *P,.05, **P,.01, ***P,.001.
doi:10.1371/journal.pone.0034553.g005
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of mesoderm [28], was 24 hours delayed when compared with
WT controls, a delay also occurring in the co-expression of SSEA-
1 and Flk1, which is representative of early mesodermal
progenitors [25]. These observations are consistent with recent
reports in which undifferentiated murine ES cells were found to
undergo mesoderm commitment when stimulated by exogenous
Dll4 [43] and, also, that Delta-mediated signalling is required for
mesoderm development in the sea urchin embryo [44]. In the
latter study, expression of Gcm, a transcription factor required for
mesoderm specification, was dependent on Delta-signalling only
for a short period of time being thereafter independent of Delta
activation. Our observation that Dll4 appears to be transiently up-
regulated prior to mesoderm formation in normal EBs is
reminiscent of the above findings, reinforcing the idea that Dll4
signalling not only regulates the timing of germ layer emergence
but also promotes mesoderm formation during EB development.
Also, the increased expression of Pax6, a marker of neuroectoder-
mal progenitors, between days 5 and 8 in Dll4
+/2 and Dll4
2/2
EBs, further suggests that Dll4 also negatively regulates the
formation of neuroectoderm in this system.
In agreement with the delay in Brachyury expression, a marked
decrease in Flk1
+ cells at days 3–3.5 was observed in Dll4
2/2 EBs
showing that the absence of Dll4 causes the almost complete
disappearance of the early Flk1
+ subpopulation where hemangio-
blasts are contained [38]. Accordingly, Dll4
2/2 EBs generated
reduced numbers of blast colonies, a phenotype that was partly
rescued by the re-introduction of the Dll4 cDNA in the parental
Dll4
2/2 ES cells. As expected, a partial rescue of the early Flk1
+
subpopulation was also observed. As all these observations would
predict, Dll4
2/2 EBs showed profound decrease in primitive and
definitive hematopoietic progenitors. In contrast, in Dll4
+/2 EBs,
the kinetics and the frequency of Flk1
+ cells were similar to the
control at these time points, and the BL-CFC potential was also
not significantly different from that of WT EBs. However, despite
their nearly normal BL-CFC numbers, a severe reduction of EryP
progenitors was found in Dll4
+/2 EBs, while definitive hemato-
poiesis was not quantitatively or qualitatively affected. Analysis of
the CFU potential of the YS from Dll4
+/2 and Dll4
2/2 embryos,
further revealed that, in vivo, Dll4 hemizygosity also specifically
affects primitive erythropoiesis. Therefore, the present data clearly
indicate that two normal Dll4 alleles are essential for the
quantitative regulation of embryonic EryP cells both in vitro and
in vivo. These observations, together with previous studies in which
the exposure of human fetal liver [45] or cord-blood [46] CD34
+
cells to exogenous Dll4 was shown to promote the growth and
differentiation of erythroid, but not of myeloid, committed
progenitors, point to a special sensitivity of the erythroid lineage
to Dll4-mediated signaling. Although the mechanistic basis for this
phenomenon remains to be determined, we observed a significant
reduction in the expression of ephrin-B2 in Dll4
+/2 EBs at day 4 of
EB development (see Figure S4B). Ephrin-B2 gene expression is
regulated by Dll4-signaling [47,48] and, ephrinB2 and its receptor
EphB4, apart from their key role on arterial-venous specification
in early embryogenesis [49,50], are also known to positively
influence the differentiation of erythropoietic progenitors, while
not affecting that of non-erythroid precursors [51,52]. Thus, it is
possible that decreased levels of EphrinB2 may contribute, at least
in part, for the specific reduction of primitive erythroid colonies
observed in Dll4
+/2 EBs.
Of note, a primitive erythropoietic phenotype opposite to that
described here has been observed by Hadland et al [9] in Notch1
null EBs, or following complete pharmacological abrogation of
Notch-signaling at day 3.5 of EB development. While studies
based on loss of function of Notch-receptors, or of Notch-ligands,
cannot inform on which Notch-ligands or Notch-receptors,
respectively, might be responsible for the observed effects, our
findings, together with those of Hadland et al [9], are highly
suggestive that the regulatory role of Notch-signaling on primitive
erythropoiesis might be the end net result of differential actions
exerted by distinct Notch-ligands. Specifically, the positive effect of
Dll4 on the emergence of primitive erythropoietic progenitors
might be counteracted by that of other ligands, akin to what has
been shown for the opposing effects of Dll4 and Jagged1 on
sprouting angiogenesis in the mouse neonatal retina [53]. Indeed,
we did observe that three other Notch-ligands genes (Dll1, Jagged1
and, to a lesser extent, Jagged2) are strongly expressed in WT-EBs
during the first 3 days of EB development (see Figure S4C). Our
data obtained from OP9 co-cultures showed that feeder-layer over
expression of Dll1 does not influence primitive erythropoiesis,
either positively or negatively. These data are compatible with the
hypothesis of a putative opposing effect of Jagged ligands with
respect to the positive effect Dll4 has on primitive erythropoiesis.
Defects in endothelial remodeling are responsible for the
embryonic lethality of mice harboring Dll4 heterozygous or
homozygous deletions. The endothelial core of Dll4
+/2 and
Dll4
2/2 blast colonies was grossly undistinguishable from that of
control colonies, indicating that the specification of endothelial
cells from the hemangioblast was not affected. However, as
recently observed [54], when whole EBs develop endothelial
sprouts through prolonged culture in methylcellulose medium,
both Dll4
+/2 and Dll4
2/2 EBs show severe defects in vascular
remodeling. Thus, similar to what is observed in vivo [15–17],
heterozygous or homozygous deletions of Dll4 do not prevent the
specification of the endothelial cells in developing EBs but severely
affect their subsequent remodeling into normal vascular structures.
In addition, a marked decrease in endothelial cells was observed in
Figure 6. Model for Dll4 influence on ES cell differentiation.
Model depicting the role of Dll4 at multiple stages of ES cell
differentiation.
doi:10.1371/journal.pone.0034553.g006
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regulates the generation of endothelium from mesodermal
endothelial progenitors [38].
Blast colonies have also been shown to give rise to vascular SMCs
[40] and, a putative defectin the generationof this celllineage could
contribute to the abnormal angiogenic phenotype observed in Dll4
mutant EBs. We observed that Dll4
+/2 and Dll4
2/2 blast colonies
cultured in conditions known to favor SMC differentiation
originated SMCs at frequencies similar to those of control colonies,
indicating that Dll4 is not necessary for the specification of this cell
lineage from the hemangioblast. Additionally, cells isolated from
day 3 Dll4
2/2 EBs (in which Flk1
+ cells are severely reduced)
originated percentages of a-SMA
+ cells similar to those of Dll4
+/2
and WT EBs upon culture in matrigel-coated wells, further
suggesting that SMC progenitors are present at normal numbers
within the Flk1
+ cells that appear in Dll4
2/2 EBs at days 4–4.5.
Together, these observations agree with previous reports showing
that the differentiation of SMCs from murine embryonic fibroblasts
(MEFs) is Dll4-independent [55] and, also, that Notch signaling is
not required for the specification of SMCs from nascent mesoderm
in chick embryos [56].
Given that the second Flk1
+ population in developing EBs also
has the potential to generate endothelial and cardiac cells [38], the
emergence of these two cell lineages was monitored in Dll4 mutant
EB cells. Expression analysis of Flk1 and Tie2, two endothelial cell
markers that are sequentially expressed during EB development
[57] revealed that endothelial cells in Dll4
2/2 EBswereconsistently
reduced throughout EB differentiation, while in Dll4
+/2 EBs a
reductionwas only visible at day 5, when compared to WT EBs. On
the other hand, we observed that the proportion of EBs exhibiting
contractile regions was increased in both Dll4
+/2 and Dll4
2/2 EBs.
Previous studies have shown that Notch activity negatively regulates
the differentiation of ES cells into cardiomyocytes [58,59]. The
present data further indicates that such an action might be
mediated, at least in part, by Dll4, an assumption that is consistent
with the observation that the Dll4 gene is highly expressed from
days 4 to 8 in developing WT-EBs, when compared to other Notch-
ligand genes (see Figure 1A and Figure S4C).
In summary, the present observations assign a role for the
Notch ligand Dll4 at early stages of hemato-vascular development,
namely in the generation of hemangioblasts and EryP progenitors.
They further show that Dll4 participates, in a dose dependent
manner, in the temporal regulation of mesoderm formation and,
subsequently, differentially regulates other mesoderm-derived cell
lineages, favoring endothelial cell differentiation and inhibiting
cardiomyogenesis while not affecting SMC specification. Further
studies will be required to identify the mechanisms by which Dll4
exerts these functions and how they relate with other major
signaling pathways crucial for early embryogenesis and hemato-
vascular development.
Materials and Methods
Ethics Statement
All animal-involving procedures in this study were approved by
the Ethics and Animal Welfare Committee from the Lisbon
Faculty of Veterinary Medicine (Permit number: CVT/71084/
2006).
ES cell lines and EB differentiation
Two previously described murine ES cell lines, R1 [60] and its
Dll4
+/2 derivative [15], were used in this study. To obtain Dll4
2/2
ES cells, the Dll4
+/2 cell line was cultured on G418-resistant MEFs
(DR4, ATCC) in the presence of 1.5 mg/ml of G418 (Sigma-
Aldrich).After15daysofculture,G418-resistantEScellcloneswere
selected and expanded. To confirm the loss of the wild-type (WT)
Dll4 allele, PCR genotyping was performed as described [15].
Three Dll4
2/2 ES cell clones(#7,#9i and #10i) were selected and
used for further studies.
Parental R1 (WT), Dll4
+/2 and Dll4
2/2 ES cell lines were
maintained on mitomycin C-inactivated MEFs in Dulbecco’s
Modified Eagle’s Medium (DMEM, Sigma-Aldrich) supplemented
with 15% fetal bovine serum (FBS), 0.1 mM b-mercaptoethanol
(GIBCO-Invitrogen), 1000 U/mL recombinant leukemia inhibi-
tory factor (Chemicon), 1% L-glutamine, 1% penicillin-strepto-
mycin, 1% non-essential amino acids and 1% nucleosides (Sigma-
Aldrich).
Two days prior the onset of differentiation, ES cells were
transferred to Iscove’s Modified Dulbecco’s Medium (IMDM,
Sigma-Aldrich) containing the above components. EBs in
suspension culture were then generated as described [61] and,
for differentiation in a semi-solid medium, ES cells were plated in
the same medium supplemented with 1% methylcellulose (M3134,
StemCell Technologies) and 40 ng/ml SCF (Peprotech). Differ-
entiation of ES cells on OP9 stromal cells was performed as
described [37].
Mouse embryos
Embryos were obtained by crossing CD1 (WT) mice with Dll4
+/2
mice in the CD1 genetic background or by the intercross of Dll4
+/2
mice as previously described [15]. The YS was dissected from the
embryo proper, which was used for PCR genotyping [15].
Embryonic age was determined by the number of somites.
Colony assays
Generation of blast colonies was performed as described [2],
except for the absence of D4T conditioned medium. For the
growth of hematopoietic progenitors, EBs or YS were dissociated
with 0.25% trypsin and the derived cells plated in 1%
methylcellulose with cytokines (M3434, StemCell Technologies).
Hematopoietic colony morphology was confirmed in May-
Gru ¨nwald-Giemsa-stained cytospins.
Endothelial and smooth muscle differentiation
Day 3 EB-derived cells and blast colonies with 4 days of
development were cultured as described [39], except for the
absence of D4T conditioned medium.
Retroviral transduction of Dll4
2/2 ES cells
The mDll4 cDNA was cloned into the EcoRI site of the
enhanced green fluorescent protein (eGFP)-expressing retroviral
vector pMigR1. Empty (pMigR1) or recombinant virus (pMigR1-
Dll4) were obtained as described [62] followed by spin-infection
[34] of Dll4
2/2 ES cells (clone #7). After 48 hours of pre-
differentiation [61], GFP
+ cells were sorted on a FACSAria
(Becton, Dickinson and Company (BD)) to .95% purity and
differentiated into EBs.
Flow cytometry
Cells were stained with the following mouse antibodies: anti-
SSEA-1-Alexa Fluor 488, anti-Flk1-PE, anti-CD41-PE, anti-Tie2-
biotin, anti-PdgfRa - APC, anti-VE-cadherin-APC (eBioscience).
Biotin was detected with FITC-conjugated streptavidin
(eBioscience). Sorting of Flk1
+ cells was performed with FACSAria
instrument (BD). Non-viable cells were excluded from the analysis
by 7-AAD (eBioscience) staining. For proliferation analysis, cells
were stained with PE Mouse Anti-human Ki-67 according to the
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assessed using Annexin V/propidium iodide (PI) detection kit
(eBioscience). Cells were analyzed on a FACSCalibur (BD) and
data analyzed using FlowJo software (TreeStar).
Immunocytochemistry and image analysis
Detection of E-cadherin during EB development was done in
three-dimensionally preserved EBs as previously described [63].
For SMCs identification, cells were fixed in 3.7% PFA/PBS,
permeabilized in 0.2% Triton X-100/PBS, blocked in 3% BSA/
0.1% Tween 20/PBS, incubated with anti-a-SMA antibody
(Abcam) followed by FITC-conjugated secondary antibody. EBs
in methylcellulose medium were fixed in 3.7% PFA/PBS, blocked
in 3% BSA/PBS and incubated with anti-CD31-biotin antibody
(BD Pharmingen) followed by FITC-conjugated streptavidin. All
preparations were mounted in Vectashield-DAPI (Vector Labo-
ratories) and visualized with a Leica DM5000B (Leica) epifluor-
escence microscope or with a confocal microscope Zeiss LSM510
META (Carl Zeiss).
Semi-quantitative and quantitative RT-PCR
Total RNA was isolated with the High Pure RNA Isolation Kit
(Roche Diagnostics), followed by reverse transcription of 2 mgo f
RNA with the SuperScript III First-Strand Synthesis System
(Invitrogen) using oligo(dT) primers. For semi-quantitative PCR,
conditions for each gene were optimized in order to detect the
exponential phase of amplification. Glyceraldehyde 3 phosphate
dehydrogenase (GAPDH) was used as a reference for the amount
of cDNA in each lane. PCR products were resolved on 1.5%
agarose gels and visualized by GelRed (Biotium) staining. Primers
and PCR conditions are listed in Table S1. Quantitative RT-PCR
(qRT-PCR) was performed with SYBR Green PCR Master Mix
(Applied BioSystems) and primers (Brachyury- PPM05479E;
Ephrin B2 - PPM03657B; GAPDH- PPM02946E; SA biosciences)
on an ABI PRISM 7500 Fast Real Time PCR System (Applied
BioSystems). The comparative Ct (2-DDCt) method was used with
GAPDH gene as an endogenous control and day 2 WT EB-
derived sample as a calibrator. Three to five biological replicates
were analyzed for each condition.
Statistical analysis
All experiments were performed at least three times, and data
are expressed as mean 6 SD. Data were analyzed by unpaired
Student’s t-test or one-way ANOVA using GraphPad Prism 5.0
software (GraphPad Software). Values of P less than .05 were
considered significant.
Supporting Information
Figure S1 Effects of Dll4 in ES cell maintenance and EB
generation. (A) Proliferation of WT, Dll4
+/2 and Dll4
2/2 ES
cells cultured for 4 days on MEFs. (B) Number of EBs generated
by WT, Dll4
+/2 and Dll4
2/2 ES cells when cultured in
suspension. (C) Cellularity of WT, Dll4
+/2 and Dll4
2/2 EBs
when cultured in suspension from day 2 to day 6. (D–E) Cell
proliferation (D) and apoptosis (E) in WT, Dll4
+/2 and Dll4
2/2
EBs, from day 2 to day 6, as determined by the percentage of Ki-
67
+ cells and Annexin V
+ cells, respectively. (F) Flow cytometry
analysis of SSEA-1 expression in WT, Dll4
+/2 and Dll4
2/2 EBs
from day 0 to day 6. =: 0.0000086,P,0.048246 from day 3.5 to
day 6. (G) Quantitative RT-PCR analysis of Brachyury in WT,
Dll4
+/2 and Dll4
2/2 EBs from day 2 to day 6 of differentiation.
m: WT and Dll4
+/2 versus all Dll4
2/2, 0.0004,P,0.0090.
(TIF)
Figure S2 Effects of Dll4 on the emergence of SSEA-1
+
cells, Flk1
+ cells, hematopoietic and endothelial cells.
(A–E) Flow cytometry analysis of SSEA-1
+ (A), SSEA-1
+/Flk1
+ (B),
Flk1
+ (C) CD41
+ (D) and Tie2
+/Flk1
+/CD41
2 (E) cells in WT,
Dll4
+/2 and Dll4
2/2 EBs. Absolute cell numbers counted at the
indicated days. ND not determined. m: WT and Dll4
+/2 versus #7,
P=0.005276 and 0.002622, respectively; %: WT and Dll4
+/2 versus
#7a n d#10i, 0.013904,P,0.046047. =:d a y3–W Ta n dD l l 4
+/2
versus #7a n d#9i, 0.0376,P,0.0459; day 3.5 – WT versus all
Dll4
2/2, 0.0228,P,0.0286; e: day 3 – WT and Dll4
+/2 versus all
Dll4
2/2 cells,0.01206,P,0.0248..:d a y4–W Tversus all Dll4
2/2
cells, 0.02517,P,0.03789; day 4.5 – WT and Dll4
+/2 versus all
Dll4
2/2 cells, 0.003056,P,0.042568; day 5 – Dll4
+/2 and #7
versus WT, P=0.012558 and 0.00922, respectively; day 6 – WT and
Dll4
+/2 versus all Dll4
2/2, 0.001036,P,0.04778. &:d a y5–
Dll4
+/2 versus #7, P=0.02404; day 6 – WT versus #7a n d#10i,
P=0.03235 and 0.04762, respectively.
(TIF)
Figure S3 Blast potential of Dll4
2/2 cells. (A) Number of
blast colonies generated by day 3 WT and Dll4
2/2 EB-cells.
Similar numbers of EBs were generated by three independent
Dll4
2/2 clones (#7, #9i, #10i). (B) Flow cytometry analysis of
Flk1
+ cells derived from day 3 EBs differentiated from Dll4
2/2 ES
cells transduced with empty (pMigR1) or recombinant virus
(pMigR1-Dll4). *P,.05, ***P,.001.
(TIF)
Figure S4 Gene expression analysis in WT, Dll4
+/2 and
Dll4
2/2 differentiating EBs. (A) Semi-quantitative RT-PCR
analysis of Scl, Gata1 and Runx1 in WT, Dll4
+/2 and Dll4
2/2 EBs
from day 0 to day 8 of differentiation. (B) Quantitative RT-PCR
analysis of Ephrin B2 in WT, Dll4
+/2 and Dll4
2/2 EBs from day 2
to day 6 of differentiation. ND not determined. *P,.05, **P,.01.
(C) Semi-quantitative RT-PCR analysis of Notch-ligand genes
Dll1, Jagged1 and Jagged2 in WT EBs from day 0 to day 8 of
differentiation.
(TIF)
Table S1 Primer sequences and conditions used for
semi-quantitative RT-PCR detection of gene expression
of relevant Notch-system components, transcription
factors and germ-layer markers, used in this study.
(DOC)
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